HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alexandra K Golant Selected Research

dupilumab

1/2023The impact of dupilumab treatment on SARS-CoV-2 T cell responses in atopic dermatitis patients.
1/2022The impact of dupilumab treatment on severe acute respiratory syndrome coronavirus 2-coronavirus disease 2019 antibody responses in patients with atopic dermatitis.
1/2022COVID-19 Symptoms Are Attenuated in Moderate-to-Severe Atopic Dermatitis Patients Treated with Dupilumab.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alexandra K Golant Research Topics

Disease

3Atopic Dermatitis (Atopic Eczema)
01/2023 - 01/2022
1COVID-19
01/2022
1Virus Diseases (Viral Diseases)
01/2022
1Scabies (Sarcoptic Mange)
01/2012

Drug/Important Bio-Agent (IBA)

3dupilumabIBA
01/2023 - 01/2022
1Ivermectin (Mectizan)FDA Link
01/2012

Therapy/Procedure

1Therapeutics
01/2012